Literature DB >> 3511956

A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. A clinical and histopathological study.

J G Aarnoudse, H J Houthoff, J Weits, E Vellenga, H J Huisjes.   

Abstract

Six women without hypertension or proteinuria, admitted for severe upper abdominal pain in the third trimester of pregnancy had elevated serum liver enzymes (SGOT, SGPT), markedly increased serum LDH levels, thrombocytopenia and abnormal blood coagulation tests, in particular low antithrombin III levels, indicating disseminated intravascular coagulation (DIC). Liver biopsies showed periportal and/or focal parenchymal lesions with large fibrin deposits, comparable to the liver lesions in eclampsia. Immunofluorescence (IF) showed microthrombi and large fibrin deposits. Three of the six women recovered spontaneously before delivery; in the remaining three all signs and symptoms rapidly disappeared after delivery. Perinatal outcome was poor. Seven women with pregnancy-induced hypertension and elevated serum liver enzymes constituted a reference series. Histopathological examination of liver biopsies in the reference group revealed periportal and/or focal parenchymal lesions in three whereas IF showed fibrin deposition in all seven, but less extensive than in the study group. The present findings indicate that upper abdominal pain in the last trimester of pregnancy can be caused by a syndrome of (pre)-eclamptic liver damage and DIC, even when hypertension and proteinuria are lacking.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511956     DOI: 10.1111/j.1471-0528.1986.tb07879.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  18 in total

Review 1.  Hemolysis, elevated liver enzymes, and low platelets in pregnancy (HELLP syndrome). A case report and literature review.

Authors:  B Schorr-Lesnick; B Dworkin; W S Rosenthal
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  A case of HELLP syndrome at 23 weeks' gestation.

Authors:  W Neuhaus; G Crombach; W Hamm; A Bolte
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 3.  HELLP syndrome: a condition of varied presentation.

Authors:  R Gleeson; J Farrell; M Doyle; J J Walshe
Journal:  Ir J Med Sci       Date:  1996 Oct-Dec       Impact factor: 1.568

4.  Spontaneous subcapsular hepatic hemorrhage associated with pregnancy: report of a case.

Authors:  G Yotsumoto; K Tanaka; N Ishizaki; A Ikoma; S Kawashima; A Taira
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 5.  Eclampsia still kills.

Authors:  C W Redman
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

6.  Isolation of periportal, midlobular, and centrilobular rat liver sinusoidal endothelial cells enables study of zonated drug toxicity.

Authors:  Guanhua Xie; Lin Wang; Xiangdong Wang; Lei Wang; Laurie D DeLeve
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-02       Impact factor: 4.052

7.  Upper abdominal pain in pregnancy may indicate pre-eclampsia.

Authors:  C Barry; R Fox; G Stirrat
Journal:  BMJ       Date:  1994-06-11

8.  Neonatal outcome after preterm delivery in HELLP syndrome.

Authors:  Hye Yeon Kim; Yong Seok Sohn; Jae Hak Lim; Euy Hyuk Kim; Ja Young Kwon; Yong Won Park; Young Han Kim
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

9.  Maternal haemolysis, elevated liver enzymes and low platelets syndrome: specific problems in the newborn.

Authors:  C M Eeltink; R A van Lingen; J G Aarnoudse; J B Derks; A Okken
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

10.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.